Aging populations and increasing cancer rates are increasing the number of samples in healthcare. Despite the growing trend of digitalisation, pathologists are still reviewing the samples manually, which is a subjective, time-cons...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MIA-NORMAL
Medical Image Analysis with Normative Machine Learning
2M€
Cerrado
EIN2020-112472
FRAMEWORK AND INFRASTRUCTURE FOR DEEP IMAGE ANALYSIS AND STO...
8K€
Cerrado
TED2021-130944B-C21
SURGERYAI-MODELS:INCORPORANDO HERRAMIENTAS DIGITALES E IA EN...
154K€
Cerrado
Deep4MI
Deep Learning for Medical Imaging Learning Clinically Usefu...
2M€
Cerrado
ProCAncer-I
An AI Platform integrating imaging data and models supporti...
10M€
Cerrado
Información proyecto AiforCancerDX
Duración del proyecto: 23 meses
Fecha Inicio: 2019-11-05
Fecha Fin: 2021-10-31
Líder del proyecto
AIFORIA TECHNOLOGIES OY
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
3M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Aging populations and increasing cancer rates are increasing the number of samples in healthcare. Despite the growing trend of digitalisation, pathologists are still reviewing the samples manually, which is a subjective, time-consuming, expensive manual process that exposes patients to the risk of misdiagnosis. Thus, there is a clear need for an affordable tool that supports and streamlines the workflows of pathologist, complementing humans with automated and objective analysis.
Aiforia® Cloud platform augments the efficiency and consistency of a pathologist’s clinical workflow. It removes the slow and inconsistent manual work by automatically performing a range of laborious image analysis tasks, in a fraction of time with unprecedented accuracy and consistency. The productivity leap is enabled by our deep learning AI software, implemented on a cloud platform, and developed specifically for pathology. The platform has been built by Aiforia Technologies Oy, a Finnish SME, bringing together a team of experts in medicine, business, and software development.
The award-winning Aiforia® Cloud is already used by more than 50 organisations for research purposes. With the AiforCancerDx project, the platform will be introduced to clinical use. We will build the world’s first ready-made deep learning algorithms for automated cancer diagnostics. The project allows Aiforia Technologies to remain at the forefront of the digital revolution of pathology and capture a significant share of the global market expected to grow to €900 million by 2020.